MIRA INFORM REPORT

 

 

Report No. :

355002

Report Date :

16.12.2015

 

IDENTIFICATION DETAILS

 

Name :

NAPROD LIFE SCIENCES PRIVATE LIMITED (w.e.f.07.12.2006)

 

 

Formerly Known As :

NEON ANTIBIOTICS PRIVATE LIMITED

 

 

Registered Office :

304, Town Centre, 3rd Floor, Andheri – Kurla Road, Andheri (East), Mumbai – 400 059, Maharashtra

Tel. No.:

91-22-42142700

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

30.07.1990

 

 

Com. Reg. No.:

11-057496

 

 

Capital Investment / Paid-up Capital :

Rs.30.200 Million

 

 

CIN No.:

[Company Identification No.]

U24230mh1990ptc057496

 

 

IEC No.:

0393037207

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMN10162F

 

 

PAN No.:

[Permanent Account No.]

AAACN1291M

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Parenterals, Tablets, Capsules Formulations and General / Sterile API’s. [Confirmed by management]

 

 

No. of Employees :

400 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (26)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject has been declared as dormant company by the government department, because the Management has not filed its financial record with government department since 2006.

 

As per our investigation, our executive had word with Mr. Ketan Shah, finance head that the company has not filed its financials after 2006 as legal case is going on against one of the director of the company. Further, he confirmed that the activities of the company are running smoothly.

 

As per our source, we able to get the financial for the year ended 2015, as per the financial the company reported healthy operational activities along with decent profitability margin and moderate financial profile with sound net worth.

 

However, business is active and subjects undertake its business operations actively.

 

The company can be considered for business dealings with great caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Ketan Shah

Designation :

Finance Head

Contact No.:

91-9326720397

Date :

12.12.2015

 

 

LOCATIONS

 

Registered Office :

304, Town Centre, 3rd Floor, Andheri – Kurla Road, Andheri (East), Mumbai – 400 059, Maharashtra, India

Tel. No.:

91-22-42142700

Mobile No.:

91-9320720397 (Mr. Ketan Shah)

Fax No.:

91-22-66490036

E-Mail :

Ketan.shah@naprodgruop.com

Website :

http://www.naprodgroup.com

 

 

factory  :

G/17/1, MIDC, Tarapur, Boisar, Thane – 401 506, Maharashtra, India 

Area:

3600 sq. ft.

Location :

Leased

 

 

DIRECTORS

 

AS ON 26.10.2006

 

Name :

Mr. Ashok Jain

Designation :

Director

Address :

15, Samhita CHS Limited, Factory Lane, Borivali (West), Mumbai – 400 092, Maharashtra, India

Date of Birth/Age :

13.09.1957

Qualification:

Graduate

Date of Appointment :

25.03.1996

 

 

Name :

Mrs. Kamla Babulal Jain

Designation :

Director    

Address :

B-83, Dattani Towers, Near Kora Kendra, S.V. Road, Borivali (West), Mumbai – 400 092, Maharashtra, India

Date of Birth/Age :

10.12.1947

Qualification:

F.Y.B.Com

Date of Appointment :

25.03.1996

Voter ID No.:

MT/09/042/007

 

 

Name :

Mr. Mohan Jain

Designation :

Director

 

 

KEY EXECUTIVES

 

Name :

Mr. Ketan Shah

Designation :

Finance Head

 

 

MAJOR SHAREHOLDERS

 

AS ON 26.10.2006

 

Names of Shareholders

No. of Shares

Uttam K. Jain

63480

Pravin K. Jain

15620

Babulal K. Jain

28000

Ashok K. Jain

127390

Babulal K. Jain (HUF)

50150

Ashok K. Jain (HUF)

17850

Chanchal Jain

95400

Karla B. Jain

109150

Shari P. Jain

200500

Manish Jain

27600

Mohan Jain

58500

Meena Jain

100900

Sunita Jain

84742

Uttam K. Jain (HUF)

54700

Abhay Jain

62792

Rahul Jain

67192

Prachi Jain

125092

Pravin K. Jain (HUF)

9750

Rohan Jain

54792

Jain Pravin-Hira and Company, India

15150

Jain B. Manish (N.AG)

11500

Sangeeta Jain

109350

Aarya Jain

100

Nisal Jain

100

Niyati Jain

10100

Mohan B. Jain (HUF)

100

TOTAL

1500000

 

AS ON 26.10.2006

 

Equity Shares Break Up

Percentage of Holding

Directors or relatives of Directors

100.00

TOTAL

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Parenterals, Tablets, Capsules Formulations and General / Sterile API’s. [Confirmed by management]

 

 

Products :

·         Anaesthetics and Allied Products

·         Antineoplast Products

·         Corticosteroids and Hormons Products

·         Antibacterials Products

·         Antitubercular Products

·         Gynaecological Products

·         Analgesic and Antipyratic Products

·         Cardiovascular Products

·         Vitamin, Haematinic and Mineral Preparations

·         Antihistamine, Cough and Cold Preparations

·         Other Specialities

  • Vetrinary Products

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

 

Products :

Finished Goods

Countries :

  • Pakistan
  • Srilanka
  • Ukraine
  • Cuba

 

 

Imports :

 

Products :

Raw Material

Countries :

China

 

 

Terms :

 

Selling :

Cash and L/C (30/60 days)

 

 

Purchasing :

Cash and L/C (30/60 days)

 

PRODUCTION STATUS (AS ON 31.03.2006)

 

Particulars

Unit

Installed Capacity

Actual Production

Injections

(Nos.) I (In Lacs)

230.00

81.83

Capsules

(Nos.) I (In Lacs)

210.00

5.36

Tablets

(Nos.) I (In Lacs)

350.00

305.31

Bulk Drugs

Kgs.

18000.00

3430.78

 

 

 

GENERAL INFORMATION

 

Suppliers :

Not Divulged

Reference :

Ketan Pharma – Mumbai

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

Customers :

  • Wholesalers
  • Retailers
  • OEM’s
  • Manufacturer

Reference :

Alkem Laboratories – Mumbai

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

No. of Employees :

350 (Approximately)

 

 

Bankers :

  • ICICI Bank Limited, Land Mark Race Cource Circle, Alkapuri, Baroda – 390 015, Gujarat, India
  • ICICI Bank Limited, Andheri (West), Mumbai, Maharashtra, India
  • State Bank of India, Tarapur Branch
  • State Bank of India, Industrial Finance Branch, Andheri (East), Mumbai – 400 069, Maharashtra, India

 

 

 

Auditors :

 

Name :

Sohan S. jain and Company

Chartered Accountants 

Address :

301, Verma Chambers, 11, Homji Street, Horniman Circle, Mumbai – 400 001, Maharashtra, India

PAN No.:

AACPJ4845Q

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Associates/Subsidiaries :

  • Mira Clause Pharma Private Limited
  • Mac Chem Products India Private Limited

 

 

CAPITAL STRUCTURE

 

 

AS ON 31.03.2015

 

Authorised Capital : Not Available

 

Issued, Subscribed & Paid-up Capital : Rs.30.200 Million

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2015

31.03.2014

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

30.200

30.200

(b) Reserves & Surplus

 

975.036

904.501

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

1005.236

934.701

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

9.931

16.754

(b) Deferred tax liabilities (Net)

 

30.959

37.104

(c) Other long term liabilities

 

3.668

4.983

(d) long-term provisions

 

0.000

0.000

Total Non-current Liabilities (3)

 

44.558

58.841

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

0.000

0.000

(b) Trade payables

 

87.078

95.371

(c) Other current liabilities

 

7.684

28.633

(d) Short-term provisions

 

34.160

52.492

Total Current Liabilities (4)

 

128.922

176.496

 

 

 

 

TOTAL

 

1178.716

1170.038

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

270.007

265.210

(ii) Intangible Assets

 

0.000

0.000

(iii) Capital work-in-progress

 

9.038

0.000

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.500

0.500

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

119.597

119.581

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

399.142

385.291

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

169.073

169.153

(c) Trade receivables

 

221.042

251.919

(d) Cash and cash equivalents

 

323.963

268.321

(e) Short-term loans and advances

 

65.496

95.354

(f) Other current assets

 

0.000

0.000

Total Current Assets

 

779.574

784.747

 

 

 

 

TOTAL

 

1178.716

1170.038

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2015

 

31.03.2014

 

SALES

 

 

 

 

 

Income

 

981.088

1265.262

 

 

Other Income

 

20.091

11.518

 

 

TOTAL                                    

 

1001.179

1276.780

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

 

474.283

606.577

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

(0.518)

33.151

 

 

Employees benefits expense

 

140.435

131.747

 

 

Other expenses

 

215.990

266.825

 

 

R and D expenses

 

26.655

31.786

 

 

TOTAL                                    

 

856.845

1070.086

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

144.334

206.694

 

 

 

 

 

Less

FINANCIAL EXPENSES                       

 

2.168

3.829

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

 

142.166

202.865

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

 

45.591

19.170

 

 

 

 

 

 

PROFIT BEFORE TAX

 

96.575

183.695

 

 

 

 

 

 

TAX                                                                 

 

22.181

48.730

 

 

 

 

 

 

PROFIT AFTER TAX

 

74.394

134.965

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

24.63

44.69

 

 

Particulars

 

 

 

31.03.2015

Sales Turnover (Approximately)

 

 

1020.000

 

 

 

(Due to less exports)

 

Expected Sales (2013-2014): Rs. 1100.000 Million

 

The above information has been parted by Mr. Ketan Shah.

 

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

 

31.03.2015

31.03.2014

Current Maturities of Long term debt

 

NA

NA

Cash generated from operations

 

NA

NA

Net cash flow from (used in) operation

 

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2015

31.03.2014

Net Profit Margin

(PAT / Sales)

(%)

 

7.58

10.67

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

 

14.71

16.34

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

 

8.26

15.71

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

 

0.10

0.20

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

 

0.01

0.02

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

6.05

4.45

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

Share Capital

30.200

30.200

Reserves & Surplus

904.501

975.036

Money received against share warrants

0.000

0.000

 Share Application money pending allotment

0.000

0.000

Net worth

934.701

1005.236

 

 

 

long-term borrowings

16.754

9.931

Short term borrowings

0.000

0.000

CURRENT MATURITIES OF LONG-TERM DEBTS

0.000

0.000

Total borrowings

16.754

9.931

Debt/Equity ratio

0.018

0.010

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

Sales

1265.262

981.088

 

 

(22.460)

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

Sales

1265.262

981.088

Profit

134.965

74.394

 

10.67%

7.58%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

----

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

Yes

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

Yes

19

Major customers

Yes

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

-----

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last two years

Yes

27

Reasons for variation <> 20%

-----

28

Estimation for coming financial year

Yes

29

Profitability for last two years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

-----

33

Market information

-----

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10150078

22/02/2007

47,500,000.00

ICICI BANK LIMITED

LANDMARKRACE COURCE CIRCLE, ALKAPURI, BARODA,

Gujarat - 390015, INDIA

A11328325

2

90240409

30/07/2002 *

19,100,000.00

STATE BANK OF INDIA

BORIVALI EAST BRANCH, MUMBAI,

Maharashtra - 400066, INDIA

-

3

90238307

31/03/1997

12,100,000.00

MAHARASHTRA STATE FINANCIAL CORPORATION

NEW EXCELSIOR BUILDING; 5TH; 7TH; 8TH & 9TH FLOORS, AMRIT KESHAV NAYAK MARG, MUMBAI,

Maharashtra - 400001, INDIA

-

4

90238283

06/12/1995

8,580,000.00

MAHARASHTRA STATE FINANCIAL CORPORATION

NEW EXCELSIOR BUILDING; 5TH; 7TH; 8TH & 9TH FLOORS, AMRIT KESHAV NAYAK MARG, BOMBAY,

Maharashtra - 400001, INDIA

-

5

90239987

01/11/1994

5,100,000.00

STATE BANK OF INDIA

BORIVALI EAST BRANCH, DATTAPADA; BORIVLI EAST, BOMBAY, Maharashtra - 400066, INDIA

-

 

* Date of charge modification

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs. 60.04

UK Pound

1

Rs. 101.67

Euro

1

Rs. 73.93

 

 

INFORMATION DETAILS

 

Information Gathered by :

DIP

 

 

Analysis Done by :

KAS

 

 

Report Prepared by :

JYO

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILITY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

2

--MARGINS

-5~5

----

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

26

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.